随机临床研究评估了vuse alto电子尼古丁输送系统的药理动力学和主观影响
Kristen Prevette1, Kristen G Jordan2, Brian M Keyser2
1RAI Services Company, 401 N Main Street, Winston-Salem, NC, 27101, USA. prevetk1@rjrt.com.
Scientific reports
|July 1, 2025
概括
Vuse Alto电子尼古丁产品的滥用责任比香烟低,比尼古丁口香糖高. 这些发现表明,Vuse Alto可能通过为吸烟者提供可燃香烟的替代品来帮助减少烟草的危害.
科学领域:
- 烟草科学 烟草科学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 美国FDA要求对预售烟草产品申请 (PMTA) 进行滥用责任 (AL) 评估,以确保公共卫生的保护.
- 电子尼古丁烟草制品 (ENDS) 越来越受欢迎,需要评估其滥用潜力.
- Vuse Alto ENDS提供不同的尼古丁度,需要进行特定的AL和尼古丁吸收研究.
研究的目的:
- 评估Vuse Alto ENDS的滥用责任 (AL) 和尼古丁吸收.
- 为了将Vuse Alto产品的AL与普通品牌 (UB) 香烟和尼古丁口香糖进行比较.
- 评估不同尼古丁度和口味对Vuse Alto的AL和用户体验的影响.
主要方法:
- 进行了两项开放标签,随机,交叉临床实验室研究.
- 研究1评估了Vuse Alto (2.4%和5%尼古丁) 的实时主观影响,生理测量 (心率,血压) 和药理动力学 (PK).
- 第二项研究评估了Vuse Alto (1.8%和2.4%尼古丁) 的PK和整体产品喜好 (OPL) 在四种口味中,其中包括UB香烟和尼古丁口香糖.
主要成果:
- 对于Vuse Alto产品的尼古丁PK配置文件在测试的尼古丁度和风味中是相似的.
- Vuse Alto (2.4%和5%的尼古丁) 显示中级AL,在主观影响和PK中处于UB香烟和尼古丁口香糖之间.
- 生理学测量表明,Vuse Alto使用时心率和血压增加. 在测试的Vuse Alto产品中,OPL是可比的.
结论:
- Vuse Alto ENDS的滥用责任明显低于可燃香烟,高于尼古丁口香糖.
- 维斯阿尔托产品有效地提供尼古丁,满足吸烟者的偏好,在尼古丁替代疗法和香烟之间.
- 这些发现表明,Vuse Alto可能通过提供一种不那么有害的吸烟替代品来帮助减少烟草的危害.
更多相关视频
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
25.8K
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
8.5K
相关概念视频
Stimulants
329
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
329
Drugs Acting on Autonomic Ganglia: Stimulants
1.5K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
